SMA Solar (S92) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Nov, 2025Executive summary
Q1 2025 group sales declined to €327.7–328 million from €362 million in Q1 2024, mainly due to weak Home and C&I segments, while Large Scale & Project Solutions grew 22.2%.
EBITDA dropped to €24.6–25 million from €50 million, reflecting lower sales and segment mix.
Free cash flow turned positive at €96 million, driven by net working capital reduction.
Order backlog remained robust at €1.29–1.3 billion, with Large Scale segment contributing the majority.
Restructuring and transformation programs underway, targeting cost reductions and efficiency gains.
Financial highlights
EBITDA margin was 7.5–8% in Q1 2025, down from 14% in Q1 2024, with a €10 million positive one-time effect from a claim settlement.
EBIT margin dropped to 3.5–4% from 10.6–11% in Q1 2024.
Net cash increased to €176.5–177 million at quarter-end, up from €84.2 million at year-end 2024.
Gross cash flow was €20.8–21 million, down from €51–51.1 million in Q1 2024.
Earnings per share fell to €0.16 from €0.82.
Outlook and guidance
2025 sales expected between €1,500–1,650 million, with EBITDA of €70–110 million; results expected in the lower third of guidance due to macroeconomic and tariff uncertainties.
EBIT guidance for 2025 is €0–50 million, with capital expenditure around €115 million.
Restructuring program targets €150–200 million EBIT improvement, with 40% of savings expected in 2025.
Cautious outlook due to macroeconomic deterioration and tariff policy uncertainties, especially impacting large scale order intake in the U.S.
Large Scale & Project Solutions to see slight sales growth; Home & Business Solutions to recover slightly.
Latest events from SMA Solar
- 2025 revenue flat, losses from one-offs, cash flow up, 2026 outlook cautious on tariffs.S92
Q4 202526 Mar 2026 - Large Scale growth offsets Home and C&I declines; cash flow and outlook remain pressured.S92
Q2 20242 Feb 2026 - Sharp sales and earnings drop, major restructuring, but Large Scale segment outperforms.S92
Q3 202414 Jan 2026 - 2024 sales and EBITDA declined, but restructuring aims for recovery and EBIT improvement in 2025.S92
Q4 202424 Dec 2025 - Sales and margins fell in H1 2025, but cash flow and restructuring efforts improved outlook.S92
Q2 202523 Nov 2025 - Large Scale growth offset by HBS losses and major restructuring; outlook remains challenging.S92
Q3 202517 Nov 2025 - Revenue and earnings fell sharply in 2024, driving a renewed focus on efficiency and innovation.S92
AGM 2025 Presentation1 Jul 2025